WELTRUZA ™ (olanzapine) for extended-release injectable suspension is the first and only once-monthly subcutaneous ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company ...

Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular” or the “Company”), an integrated biopharmaceutical company committed to ...

Oxford Brain Diagnostics (OBD), a pioneer in quantitative brain biology, today announced new research demonstrating that its ...

Argenx shares have fallen more than 13% after the surprise futility finding, which overshadowed a mid-stage celiac disease ...

For the second time in a week, Zealand Pharma’s weight loss pipeline has delivered mixed results, this time in a Phase 2 ...

Guardant360 CDx can now help identify cancer mutations earlier and drive improved patient outcomes in major global ...

AbCellera (Nasdaq: ABCL) today announced an upcoming poster presentation of Phase 1/2 data on ABCL635 at The Menopause ...

With the patent court siding with Halozyme, Merck faces restrictions on a product that won approval in Europe last year.

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

Ginkgo Bioworks (NYSE: DNA) today announced that it will provide in-kind access to its autonomous laboratory in Boston to ...

Solu Therapeutics, a biotechnology company pioneering novel therapies to eliminate disease-driving cells in cancer, ...